Wan Mohammad Hafiz Wan Razali

Dr. Wan Mohammad Hafiz Wan Razali

Forensic Pathology, Universiti Teknologi MARA (UiTM), Sungai Buloh, Selangor, Malaysia
+1
orcid

Research Focus & Metrics

Academic Career Length

14Years (2013-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2015 in Hypertension
Verified
Journal Article
Closed access
PDF file
AGAmanda E. Garza
Amanda E. Garza
CRChevon M. Rariy
Chevon M. Rariy
BSBei Sun
Bei Sun
JWJonathan S. Williams
Jonathan S. Williams
Jessica Lasky-SuJessica Lasky-Su
Jessica Lasky-Su
GWGordon H. Williams
Gordon H. Williams
Striatin is a novel protein that interacts with steroid receptors and modifies rapid, nongenomic activity in vitro. We tested the hypothesis that striatin would in turn affect mineralocorticoid receptor function and consequently sodium, water, and blood pressure homeostasis in an animal model. We evaluated salt sensitivity of blood pressure in novel striatin heterozygote knockout mice. Compared with wild type, striatin heterozygote exhibited a significant increase in blood pressure when sodium intake was increased from restricted (0.03%) to liberal (1.6%) sodium. Furthermore, renal expression of mineralocorticoid receptor and its genomic downstream targets serum/glucocorticoid-regulated kinase 1, and epithelial sodium channel was increased in striatin heterozygote versus wild-type mice on liberal sodium intake while the pAkt/Akt ratio, readout of mineralocorticoid receptor’s rapid, nongenomic pathway, was reduced. To determine the potential clinical relevance of these findings, we tested the association between single nucleotide polymorphic variants of striatin gene and salt sensitivity of blood pressure in 366 white hypertensive subjects. HapMap-derived tagging single nucleotide polymorphisms identified an association of rs2540923 with salt sensitivity of blood pressure (odds ratio, 6.25; 95% confidence interval, 1.7–20; P =0.01). These data provide the first in vivo evidence in humans and rodents that associates striatin with markers of mineralocorticoid receptor activity. The data also support the hypothesis that the rapid, nongenomic mineralocorticoid receptor pathway (mediated via striatin) has a role in modulating the interaction between salt intake and blood pressure.

1 September 2015 in Hypertension
Verified
Journal Article
Closed access
PDF file
AGAmanda E. Garza
Amanda E. Garza
LPLuminita H. Pojoga
Luminita H. Pojoga
BMBurhanuddin Moize
Burhanuddin Moize
WRWan Mohammad Hafiz Wan Razali
Wan Mohammad Hafiz Wan Razali
LOLauren A. Opsasnick
Lauren A. Opsasnick
RKRaouf Khalil
Raouf Khalil
Striatin is a protein regulator of vesicular trafficking in neurons that also binds caveolin-1 and Ca 2+ -calmodulin and could activate endothelial nitric oxide synthase. We have shown that striatin colocalizes with the mineralocorticoid receptor and that mineralocorticoid receptor activation increases striatin levels in vascular cells. To test whether striatin is a regulator of vascular function, wild-type and heterozygous striatin-deficient mice (Strn +/− ) were randomized in crossover intervention to restricted (0.03%) and liberal sodium (1.6%) diets for 7 days on each diet, and blood pressure and aortic vascular function were measured. Compared with wild-type, sodium restriction significantly reduced blood pressure in Strn +/− . On liberal salt intake, phenylephrine and high KCl caused a greater vascular contraction in Strn +/− than wild-type, and endothelium removal, nitric oxide synthase inhibitor L-NAME, and guanylate cyclase inhibitor ODQ enhanced phenylephrine contraction to a smaller extent in Strn +/− than wild-type. On liberal salt, acetylcholine relaxation was less in Strn +/− than in wild-type, and endothelium removal, L-NAME, and ODQ blocked acetylcholine relaxation, suggesting changes in endothelial NO-cGMP. On liberal salt, endothelial nitric oxide synthase mRNA expression and the ratio of endothelial nitric oxide synthase activator pAkt/total Akt were decreased in Strn +/− versus wild-type. Vascular relaxation to NO donor sodium nitroprusside was not different among groups. Thus, striatin deficiency is associated with salt sensitivity of blood pressure, enhanced vasoconstriction, and decreased vascular relaxation, suggesting a critical role for striatin, through modulation of endothelial NO-cGMP, in regulation of vascular function and BP during changes in sodium intake.

2 August 2024 in Diseases
Verified
Journal Article
Open access
PDF file
AAAmilia Aminuddin
Amilia Aminuddin
NSNazirah Samah
Nazirah Samah
UVUbashini Vijakumaran
Ubashini Vijakumaran
NRNur Aishah Che Roos
Nur Aishah Che Roos
FNFaridah Mohd Nor
Faridah Mohd Nor
AUAzizah Ugusman
Azizah Ugusman
Coronary artery disease (CAD) is the leading cause of death globally and is a heart condition involving insufficient blood supply to the heart muscle due to atherosclerotic plaque formation. Atherosclerosis is a chronic disease in which plaques, made up of fat, cholesterol, calcium, and other substances, build up on the inner walls of arteries. Recently, there has been growing interest in finding reliable biomarkers to understand the pathogenesis and progression of atherosclerosis. Tissue Inhibitors of Metalloproteinases (TIMPs) have emerged as potential candidates for monitoring atherosclerotic development. TIMPs are a family of endogenous proteins that regulate matrix metalloproteinases (MMPs), enzymes involved in remodeling the extracellular matrix. A systematic search using Prisma guidelines was conducted and eleven studies were selected from four different databases: Web of Science (WOS), Scopus, Ovid, and PubMed. The Newcastle–Ottawa Scale (NOS) score was used to assess the risk of bias for each study. A meta-analysis was performed, and the hazard ratio (HR) and its 95% confidence interval (CI) were determined. Among the eleven studies, six reported a positive association between higher levels of TIMPs and an increased risk of atherosclerosis. Conversely, four studies support low TIMPs with high CAD risk and one study showed no significant association between TIMP-2 G-418C polymorphism and CAD. This divergence in findings underscores the complexity of the relationship between TIMPs, atherosclerosis, and CAD. In addition, a meta-analysis from two studies yielded a HR (95% CI) of 1.42 (1.16–1.74; p < 0.001; I2 = 0%) for TIMP-2 in predicting major adverse cardiovascular events (MACEs). In conclusion, the existing evidence supports the notion that TIMPs can serve as biomarkers for predicting the severity of atherosclerosis, myocardial damage, and future MACEs among CAD patients. However, further exploration is warranted through larger-scale human studies, coupled with in vitro and in vivo investigations.


19 July 2024
Verified
Report
Closed access
AAAmilia Aminuddin
Amilia Aminuddin
UVUbashini Vijakumaran
Ubashini Vijakumaran
NSNazirah Samah
Nazirah Samah
FNFaridah Mohd Nor
Faridah Mohd Nor
WRWan Mohammad Hafiz Wan Razali
Wan Mohammad Hafiz Wan Razali
AUAzizah Ugusman
Azizah Ugusman
INPLASY202470070 Unveiling TIMPs: A Systematic Review of Their Role as Biomarkers in Atherosclerosis and Coronary Artery Disease Keywords: Tissue inhibitor of metalloproteinases; atherosclerosis; I…

Verified
Journal Article
Open access
PDF file
AAAmilia Aminuddin
Amilia Aminuddin
NSNazirah Samah
Nazirah Samah
FNFaridah Mohd Nor
Faridah Mohd Nor
WRWan Mohammad Hafiz Wan Razali
Wan Mohammad Hafiz Wan Razali
BCBeh Boon Cong
Beh Boon Cong
AUAzizah Ugusman
Azizah Ugusman
Matrix metalloproteinases (MMPs) and their tissue inhibitors (TIMPs) regulate extracellular matrix remodeling and contribute to the pathogenesis of coronary artery disease (CAD). This study examined the associations between MMP-2, MMP-9, and TIMP-3 and coronary atherosclerotic burden and cardiac function among smokers and non-smokers across the CAD spectrum. A total of 180 male participants were enrolled and divided into six groups (n = 30 per group): acute coronary syndrome (ACS) smokers, ACS non-smokers, chronic coronary syndrome (CCS) smokers, CCS non-smokers, control smokers, and control non-smokers. Serum MMP-2, MMP-9, and TIMP-3 levels were measured using ELISA. Coronary artery plaque severity was assessed using the Gensini score, while cardiac function was evaluated by echocardiography. MMP-9 and TIMP-3 levels were significantly higher in CCS patients than in controls, regardless of smoking status. MMP-9 showed significant positive correlations with the Gensini score in smokers (r = 0.556, p < 0.001) and non-smokers (r = 0.596, p < 0.001) and remained independently associated with coronary plaque severity in both groups. TIMP-3 was independently associated with the Gensini score only in non-smokers (B = 0.667, p = 0.031). Higher MMP-9 levels were independently associated with reduced left ventricular ejection fraction and adverse diastolic parameters. Overall, MMP-9 was independently associated with coronary atherosclerotic burden and cardiac dysfunction, supporting its potential as a biomarker of CAD severity. ACS, rather than smoking status, appeared to have a greater influence on cardiac dysfunction.